We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSD icon
1376
Simpson Manufacturing
SSD
$8.16B
$14.2M 0.01%
176,515
-3,794
-2% -$296K
VSAT icon
1377
Viasat
VSAT
$11.1B
$14.1M 0.01%
193,239
-13,272
-6% -$949K
VIAV icon
1378
Viavi Solutions
VIAV
$9.66B
$14.1M 0.01%
942,917
-7,358
-0.8% -$110K
CRI icon
1379
Carter's
CRI
$1.47B
$14.1M 0.01%
129,265
-5,043
-4% -$511K
KTB icon
1380
Kontoor Brands
KTB
$4.26B
$14.1M 0.01%
335,817
-1,682
-0.5% -$63.5K
HTLD icon
1381
Heartland Express
HTLD
$956M
$14M 0.01%
665,462
-10,726
-2% -$230K
CWEN.A
1382
DELISTED
Clearway Energy Class A
CWEN.A
$14M 0.01%
730,126
-51,466
-7% -$948K
INSM icon
1383
Insmed
INSM
$28.6B
$13.9M 0.01%
584,112
+114,232
+24% +$2.32M
ICPT
1384
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$13.9M 0.01%
112,485
-1,542
-1% -$138K
QVCGA
1385
DELISTED
QVC Group Inc Series A
QVCGA
$13.9M 0.01%
34,032
+5,300
+18% +$2.39M
SSB icon
1386
SouthState Bank Corp
SSB
$10.5B
$13.9M 0.01%
160,256
+9,542
+6% +$774K
GTLS
1387
DELISTED
Chart Industries
GTLS
$13.9M 0.01%
205,784
-3,549
-2% -$207K
SPNT icon
1388
SiriusPoint
SPNT
$2.68B
$13.9M 0.01%
1,319,952
+1,894
+0.1% +$18.4K
CFR icon
1389
Cullen/Frost Bankers
CFR
$10.2B
$13.9M 0.01%
142,004
-6,495
-4% -$603K
AX icon
1390
Axos Financial
AX
$5.68B
$13.9M 0.01%
457,899
-10,783
-2% -$315K
TDW icon
1391
Tidewater
TDW
$4.12B
$13.9M 0.01%
719,128
+15,960
+2% +$255K
KFRC icon
1392
Kforce
KFRC
$1.06B
$13.8M 0.01%
348,560
+28,642
+9% +$1.13M
MEDP icon
1393
Medpace
MEDP
$16.5B
$13.8M 0.01%
164,531
-239,479
-59% -$18.5M
MRNA icon
1394
Moderna
MRNA
$23.6B
$13.8M 0.01%
723,060
-14,651
-2% -$260K
ARCH
1395
DELISTED
Arch Resources, Inc.
ARCH
$13.7M 0.01%
190,766
-40,073
-17% -$3.07M
NWSA icon
1396
News Corp Class A
NWSA
$15.4B
$13.7M 0.01%
967,164
-67,596
-7% -$910K
PRO
1397
DELISTED
PROS Holdings
PRO
$13.7M 0.01%
227,857
-39,791
-15% -$2.3M
H icon
1398
Hyatt Hotels
H
$16.7B
$13.6M 0.01%
151,543
-14,462
-9% -$1.13M
RMR icon
1399
The RMR Group
RMR
$332M
$13.6M 0.01%
297,740
+62,908
+27% +$2.92M
USNA icon
1400
Usana Health Sciences
USNA
$286M
$13.6M 0.01%
172,993
-54,209
-24% -$3.99M

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.